STAR Cape+BKM120 MBC With Brain Met
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
- Status
- TERMINATED
- Phase
- PHASE2
Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
- Status
- COMPLETED
- Phase
- PHASE3
AR and ER Imaging in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Lapatinib Plus Trastuzumab or Lapatinib Plus Capecitabine in Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Maintenance Bevacizumab or Observation After Taxane Based First Line Chemotherapy In Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
A Study of Vantictumab (OMP-18R5) in Combination With Paclitaxel in Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Changes in Phenotype and Genotype of Breast Cancers During the Metastatic Process and Optimization of Therapeutic Targeting (ESOPE)
- Status
- TERMINATED
- Phase
- NA
Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)
- Status
- COMPLETED
- Phase
- PHASE3
First Line Metastatic Breast Cancer Treatment (ESMERALDA)
- Status
- COMPLETED
- Phase
- PHASE2
IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
- Status
- COMPLETED
- Phase
- NA
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
8 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Polymorphism Interaction to Predict Bevacizumab Efficacy
- Status
- COMPLETED
- Phase
- N/A
Phase II Study of Capecitabine and Cisplatin to Treat Metastatic Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2